IceCure Medical Ltd
ICCM
$1.13
-$0.015-1.32%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -49.55% | 20.78% | 24.22% | 1.43% | |
| Total Depreciation and Amortization | -1.20% | 3.80% | 12.16% | 17.14% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 828.26% | 221.67% | -88.32% | 105.22% | |
| Change in Net Operating Assets | -216.58% | 300.45% | 129.97% | -43.01% | |
| Cash from Operations | -56.94% | 40.49% | 35.25% | 10.55% | |
| Capital Expenditure | 93.83% | 91.67% | 19.00% | 74.16% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -100.02% | -153.31% | 416.05% | 57.18% | |
| Cash from Investing | -100.08% | -156.28% | 442.00% | 74.94% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 2,235.29% | -- | -99.53% | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 1,519.12% | -- | -99.50% | -- | |
| Foreign Exchange rate Adjustments | -102.63% | 102.22% | 132.65% | -223.53% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -146.32% | 48.73% | -40.23% | 177.11% | |